Search results
Stroke Following TAVR in Women
Author(s):
Mirvat Alasnag
,
Giulia Masiero
,
Chiara de Biase
,
et al
Added:
3 months ago
Review Article
Author(s):
Anne Alexandrov
Added:
1 year ago
AHA ISC 2024 — Dr Anne Alexandrov (University of Tennessee Health Science Center, US) joins us to summarise the key findings from the Zero Degree Head Positioning in Hyperacute Large Artery Ischaemic Stroke (ZODIAC) trial (NCT03728738).ZODIAC is a prospective randomized open blinded endpoint (PROBE) clinical trial investigating head positioning in hyperacute LVO ischemic stroke treatment. It aims…
View more
Author(s):
Sunny Goel
Added:
7 months ago
New York Valves 2025 - Dr Sunny Goel (Mount Sinai Hospital, New York, US) joins us to discuss the current devices and strategies that are used for embolic protection and stroke prevention in transcatheter aortic valve replacement (TAVR). Dr Goel highlights the lack of strong guidelines in the field and shares findings from recent studies investigating embolic protection devices.Interview…
View more
Added:
5 months ago
Source:
Transcatheter Academy
A large-scale meta-analysis suggests that for patients with severe symptomatic aortic stenosis (AS) at a low- to intermediate-surgical risk, transcatheter aortic valve implantation (TAVI) is associated with a lower risk of all-cause death or any stroke at one year compared with surgical aortic valve replacement (SAVR).¹This study was an individual participant data (IPD) meta-analysis of four…
View more
Author(s):
Eloi Marijon, Marek Grygier, Melanie Gunawardene
Start date:
Nov 27, 2024
Added:
1 week ago
Source:
Radcliffe Vascular
The optimal management for asymptomatic carotid stenosis has been a subject of debate, particularly with advancements in medical therapy. New findings from the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) provide clarity, suggesting a benefit for carotid-artery stenting when added to intensive medical management.¹MethodologyCREST-2 involved…
View more
Added:
3 weeks ago
Source:
Radcliffe Vascular
The optimal management for patients with high-grade asymptomatic carotid stenosis remains a key clinical question, particularly with advancements in medical therapy and revascularisation techniques. The CREST-2 trials were designed to assess whether adding revascularisation to intensive medical management provides a greater benefit than intensive medical management alone in this patient…
View more
Author(s):
Davide Capodanno
,
Sneha Shah Jain
Added:
5 months ago
Presented at the European Society of Cardiology (ESC) Congress 2025, Prof Carolyn Lam (Singapore, UK), Prof Davide Capodanno (Catania, IT), Dr Sneha Shah Jain (Stanford, US) and Prof Jeffrey Weitz (Hamilton, CA) examine the prevalence and challenges of stroke prevention in atrial fibrillation (AF) and after acute coronary syndrome (ACS). The faculty review current treatment guidelines, explore…
View more
Jesse Dawson
Job title: Professor of Stroke Medicine and Consultant Physician
Author
Author(s):
Harriette Van Spall
,
Rajesh Kharbanda
Added:
9 months ago
ACC 25 - PROTECT-TAVI shows no benefit to routine use of cerebral embolic protection during transcatheter aortic valve implantation (TAVI).Dr Harriette Van Spall (McMaster University, CA) is joined by Prof Rajesh Kharbanda (Oxford University Hospitals NHS Foundation Trust, UK) to discuss the findings from the British Heart Foundation's PROTECT-TAVI Trial, which aimed to determine whether using…
View more